How should I adjust the insulin and oral medication regimen for a patient with hemoglobin A1c 10% who is currently taking insulin glargine (Lantus) 16 U daily, insulin lispro (Admelog) 8 U per meal, and metformin 1000 mg twice daily?

Insulin and Medication Adjustment for A1C 10%

With an A1C of 10% on your current regimen, you need aggressive insulin dose escalation: increase Lantus by 10-20% (to approximately 18-20 units daily) and titrate prandial Admelog more aggressively (increase by 2 units per meal, targeting 10-12 units per meal), while continuing metformin 1000 mg twice daily and strongly considering addition of a GLP-1 receptor agonist. 1

Why This Approach

Your A1C of 10% indicates severe hyperglycemia requiring immediate intensification. The 2025 ADA Standards explicitly state that when A1C ≥10%, insulin is essential and should be aggressively titrated 1. Your current total daily insulin dose of only 40 units (16 basal + 24 prandial if taking 8 units three times daily) is inadequate.

Specific Titration Strategy

Basal Insulin (Lantus) Adjustment

• Increase by 2 units every 3 days until fasting plasma glucose reaches 80-130 mg/dL (4.4-7.2 mmol/L) 1, 2
• Target dose likely 20-30 units based on your current control
• If hypoglycemia occurs, reduce by 10-20% 1
• Monitor fasting glucose daily during titration

Prandial Insulin (Admelog) Adjustment

• Increase each meal dose by 1-2 units or 10-15% every 3 days 1
• Titrate based on 2-hour postprandial glucose readings
• Target postprandial glucose <180 mg/dL (10 mmol/L)
• Consider starting with the largest meal first if resources are limited

Critical Addition: GLP-1 Receptor Agonist

You should strongly consider adding a GLP-1 receptor agonist to this regimen 1. The guidelines explicitly recommend GLP-1 RAs when A1C remains above goal on basal-bolus insulin. This provides:

• Additional A1C reduction of 1-2%
• Weight loss benefit (counteracting insulin-associated weight gain)
• Reduced hypoglycemia risk
• Cardiovascular benefits if you have established CVD

Fixed-ratio combinations (iGlarLixi or IDegLira) are specifically mentioned as appropriate options 1.

Continue Metformin

Keep metformin 1000 mg twice daily 1. Metformin combined with insulin reduces weight gain, lowers required insulin doses, and decreases hypoglycemia compared to insulin alone.

Monitoring Requirements

• Check fasting glucose daily to titrate basal insulin
• Check 2-hour postprandial glucose after each meal to titrate prandial doses
• Reassess A1C in 3 months 1
• Prescribe glucagon for emergency hypoglycemia 1, 2

Common Pitfalls to Avoid

Therapeutic inertia is your enemy. The guidelines emphasize reassessing and modifying every 3-6 months 1. With A1C at 10%, you're at high risk for complications—every month of delay matters for morbidity and mortality.

Don't undertitrate out of fear of hypoglycemia. At A1C 10%, hyperglycemia is the immediate threat. Research shows that aggressive early insulin intensification improves long-term outcomes 3.

Watch for "overbasalization": If you push basal insulin too high without adequate prandial coverage, you'll see hypoglycemia between meals but persistent postprandial hyperglycemia. Signs include large bedtime-to-morning glucose differentials 1.

Expected Outcomes

With proper titration, expect:

• A1C reduction of 2-3% over 3-6 months
• Basal insulin dose likely 0.3-0.5 units/kg/day
• Total daily insulin 0.5-1.0 units/kg/day
• Some weight gain (3-4 kg typical), mitigated by GLP-1 RA addition 4, 5

Rotate injection sites (abdomen, thigh, deltoid) to prevent lipohypertrophy, which impairs insulin absorption 1, 2.